Ariad Pharmaceuticals Inc fka ARIA

[STOCKSEEK]

ARIAD Pharmaceuticals director just picked up 5,200 shares


Sarah J. Schlesinger, a director of ARIAD Pharmaceuticals, recently acquired 5,200 shares of the company. The buys took place at prices ranging from $5.52 to $5.93 per share, on dates ranging from August 12 to September 10, 2014. Schlesinger now owns 17,700 shares of the company. Schlesinger operates out of Cambridge, MA. Some additional info was provided as follows:

Shares were purchased pursuant to a 10b5-1 plan.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.

To receive a free e-mail notification whenever ARIAD Pharmaceuticals makes a similar move, sign up!